These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17975003)

  • 1. Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
    Harrell JC; Dye WW; Harvell DM; Pinto M; Jedlicka P; Sartorius CA; Horwitz KB
    Cancer Res; 2007 Nov; 67(21):10582-91. PubMed ID: 17975003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
    Harrell JC; Dye WW; Allred DC; Jedlicka P; Spoelstra NS; Sartorius CA; Horwitz KB
    Cancer Res; 2006 Sep; 66(18):9308-15. PubMed ID: 16982776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
    Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
    Yang F; Foekens JA; Yu J; Sieuwerts AM; Timmermans M; Klijn JG; Atkins D; Wang Y; Jiang Y
    Oncogene; 2006 Mar; 25(9):1413-9. PubMed ID: 16261164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH; Buchmann J
    Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Trinh XB; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    J Pathol; 2007 Sep; 213(1):56-64. PubMed ID: 17674348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer.
    Sutherland TE; Schuliga M; Harris T; Eckhardt BL; Anderson RL; Quan L; Stewart AG
    Clin Cancer Res; 2005 Mar; 11(5):1722-32. PubMed ID: 15755993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
    Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
    Koda M; Sulkowski S; Garofalo C; Kanczuga-Koda L; Sulkowska M; Surmacz E
    Horm Metab Res; 2003; 35(11-12):794-801. PubMed ID: 14710360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
    Wang Z; Dahiya S; Provencher H; Muir B; Carney E; Coser K; Shioda T; Ma XJ; Sgroi DC
    Clin Cancer Res; 2007 Nov; 13(21):6327-34. PubMed ID: 17975144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.
    Auer D; Reimer D; Porto V; Fleischer M; Roessler J; Wiedemair A; Marth C; Müller-Holzner E; Daxenbichler G; Zeimet AG
    Breast Cancer Res Treat; 2009 Jul; 116(1):103-11. PubMed ID: 18618240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
    Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
    Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of presence of progesterone receptors to prognosis in early breast cancer.
    Pichon MF; Pallud C; Brunet M; Milgrom E
    Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
    Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.